Silence Therapeutics Plc - American Depository Share — Quarterly Financial Statistics (NASDAQ:SLN) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Cash from operating activities -12.31 M-21.78 M-10.89 M-17.29 M-15.6 M1.52 M -42.26 M Cash from investing activities -44.38 M-1.56 M51.29 M-53.34 M10 M64.94 M 72.89 M Cash from financing activities 14 K1 0000002 000 2 000 Free cash flow -12.31 M-21.78 M-10.89 M-17.29 M-15.6 M1.52 M -42.26 M

News

Silence Therapeutics: Making Some Recent Noise (NASDAQ:SLN)

Silence Therapeutics plc (SLN) Discusses Top-Line Results From SANRECO Phase II Trial of Divesiran in Polycythemia Vera - Slideshow (NASDAQ:SLN) 2026-08-11

Silence Therapeutics plc (SLN) Discusses Top-Line Results From SANRECO Phase II Trial of Divesiran in Polycythemia Vera Transcript

SLN Stock Skyrockets 107% in Six Months: Here's What You Need to Know

Silence Therapeutics (SLN) Moves 7.2% Higher: Will This Strength Last?

Silence Therapeutics: PV Data Could Wake The Stock (Initiating Buy) (NASDAQ:SLN)

Silence Therapeutics (SLN) Surges 26.0%: Is This an Indication of Further Gains?

Why Is Silence Therapeutics Stock Soaring Wednesday? - Silence Therapeutics (NASDAQ:SLN)

Silence: 'Buy' Zerlasiran Program Shift And Divesiran Results August 2026 (NASDAQ:SLN)

Silence Therapeutics (SLN) Soars 19.0%: Is Further Upside Left in the Stock?

Silence Therapeutics earnings beat by $0.11, revenue fell short of estimates

Jefferies reiterates Buy on Silence Therapeutics stock ahead of data